American Council on Pharmaceutical Education: Annual report 2000-2001, The
Vlasses, Peter H
Annual Report: January 17, 2000 to January 14, 2001
This is the 70th annual report of the American Council on Pharmaceutical Education (ACPE). This report summarizes the ACPE’s activities covering the period January 17, 2000 to January 14, 2001, and is available to the profession and to the general public.
Meetings
The ACPE Board of Directors met June 16-18, 2000, in New Orleans, Louisiana, to take action on evaluations conducted during the spring of 2000. They also met January 11-14, 2001 in Celebration, Florida, to take action on evaluations conducted during the fall of 2000. The ACPE Public Interest Panel met June 12, 2000, and January 8, 2001, in Chicago, Illinois.
PROFESSIONAL PROGRAMS OF COLLEGES AND SCHOOLS OF PHARMACY
Accreditation Actions Taken
On the basis of self-studies, on-site evaluations conducted during the reporting year, communications received from the institutions, ongoing review of first-time NAPLEX passing rates and entry class size and comments of the Public Interest Panel, the ACPE determined the accreditation status along with specified terms and conditions of 25 professional programs, representing 19 Colleges or Schools of Pharmacy. (Note: The Directory of Accredited Professional Degree Programs of Colleges and Schools of Pharmacy designates the respective accreditation status of all programs accredited by ACPE and the academic year for the next currently scheduled evaluation of the professional programs.) The accreditation actions taken are as follows:
Auburn University School of Pharmacy
Doctor of Pharmacy program: accreditation was continued.
Howard University College of Pharmacy, Nursing and Allied Health Sciences School of Pharmacy
Doctor of Pharmacy program: accreditation was continued.
Western University of Health Sciences College of Pharmacy
Doctor of Pharmacy program: full accreditation status was granted.
Midwestern University Chicago College of Pharmacy
Doctor of Pharmacy program: accreditation was continued. In accord with the College’s professional program transition, the accreditation of the Baccalaureate in Pharmacy program extends to June 30, 2003.
University of Louisiana at Monroe College of Pharmacy
Doctor of Pharmacy program: Candidate accreditation status was granted. In accord with the College’s professional program transition, the accreditation of the Baccalaureate in Pharmacy program extends to June 30, 2002.
University of Maryland School of Pharmacy
Doctor of Pharmacy program: accreditation was continued.
Massachusetts College of Pharmacy and Health Sciences– Worcester
Doctor of Pharmacy program: precandidate accreditation status was granted.
University of Mississippi School of Pharmacy
Doctor of Pharmacy program: accreditation was continued.
University of Montana School of Pharmacy and Allied Health Sciences
Doctor of Pharmacy program: full accreditation status was granted.
University of Nebraska College of Pharmacy
Doctor of Pharmacy program: accreditation was continued.
Rutgers, the State University of New Jersey College of Pharmacy
Doctor of Pharmacy program: accreditation was continued. In accord with the College’s professional program transition, the accreditation of the Baccalaureate in Pharmacy program extends to June 30, 2003.
University of Cincinnati College of Pharmacy
Doctor of Pharmacy program: accreditation was continued. In accord with the College’s professional program transition, the accreditation of the Baccalaureate in Pharmacy program extends to June 30, 2002.
University of Oklahoma Health Sciences Center College of Pharmacy
Doctor of Pharmacy program: accreditation was continued.
Wilkes University School of Pharmacy
Doctor of Pharmacy program: In June 2000, candidate accreditation was continued and in January 2001 full accreditation status was granted.
University of Puerto Rico Medical Sciences Campus School of Pharmacy
Doctor of Pharmacy program: Candidate accreditation status was granted pending approval by the local education authority. In accord with the School’s professional program transition, the accreditation of the Baccalaureate in Pharmacy program extends to June 30, 2002.
Texas Southern University School of Pharmacy
Doctor of Pharmacy program: accreditation was continued. In accord with the College’s professional program transition, the accreditation of the Baccalaureate in Pharmacy program extends to August 31, 2001.
Texas Tech University Health Sciences Center School of Pharmacy
Doctor of Pharmacy program: full accreditation status was granted.
Shenandoah University Bernard J. Dunn School of Pharmacy
Doctor of Pharmacy program: full accreditation status was granted.
University of Wyoming School of Pharmacy
Doctor of Pharmacy program: full accreditation status was granted.
Consideration of Applications for Pre-accreditation (Pre-candidate or Candidate) Status
The following requests for pre-candidate or candidate status of a Doctor of Pharmacy program were considered on the basis of an application and presentation. It should be noted that authorization of an on-site evaluation neither implies nor infers full accreditation or complete acceptance of the planning presented in the Application, to date, but rather represents a companion element in the fact finding process necessary to the decision-making of the Council. Moreover, it should be understood that the ACPE may grant or deny candidate status based upon the evaluation process set forth.
University of California, San Diego School of Pharmacy
An on-site evaluation was authorized following the identification of a Dean for the School of Pharmacy, so as to provide the basis for the Council’s consideration of pre-candidate accreditation status.
Palm Beach Atlantic College School of Pharmacy
An on-site evaluation was authorized to be conducted during Spring 2001, so as to provide the basis for the Council’s consideration of pre– candidate accreditation status at its June 2001 meeting.
Southern Nevada Education Services Nevada College of Pharmacy
An on-site evaluation was authorized to be conducted during Spring 2001, so as to provide the basis for the Council’s consideration of candidate accreditation status at its June 2001 meeting.
Lake Erie College of Osteopathic Medicine School of Pharmacy
An on-site evaluation was authorized to be conducted following the identification of a Dean for the School of Pharmacy, so as to provide the basis for the Council’s consideration of pre-candidate accreditation status.
Monitoring During the Accreditation Period Interim Reports
Interim reports for the professional programs of the following Colleges or Schools were reviewed: Samford University McWhorter School of Pharmacy, University of Arizona College of Pharmacy, University of Connecticut School of Pharmacy, Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy, Mercer University Southern School of Pharmacy, University of Georgia College of Pharmacy, Idaho State University College of Pharmacy, University of Illinois at Chicago College of Pharmacy, Butler University College of Pharmacy and Health Sciences, Purdue University School of Pharmacy and Pharmacal Sciences, Drake University College of Pharmacy and Health Sciences, Massachusetts College of Pharmacy and Allied Health Sciences-Boston Campus, Massachusetts College of Pharmacy and Health Sciences School of Pharmacy – Worcester, Northeastern University Bouve College of Health Sciences School of Pharmacy, University of Michigan College of Pharmacy, Wayne State University College of Pharmacy and Allied Health Professions, Creighton University School of Pharmacy and Allied Health Professions, University of Minnesota College of Pharmacy, Long Island University Arnold and Marie Schwartz College of Pharmacy and Health Sciences, St. John’s University College of Pharmacy and Allied Health Professions, University of Buffalo School of Pharmacy and Pharmaceutical Sciences, Campbell University School of Pharmacy, University of North Carolina School of Pharmacy, North Dakota State University College of Pharmacy, Ohio Northern University College of Pharmacy, Ohio State University College of Pharmacy, University of Toledo College of Pharmacy, Southwestern Oklahoma State University School of Pharmacy, Oregon State University College of Pharmacy, University of the Sciences in Philadelphia Philadelphia College of Pharmacy, University of Puerto Rico School of Pharmacy, University of Pittsburgh School of Pharmacy, University of Rhode Island College of Pharmacy, Medical University of South Carolina College of Pharmacy, South Dakota State University College of Pharmacy, Texas Southern University College of Pharmacy and Health Sciences, University of Houston College of Pharmacy, and the University of Wisconsin College of Pharmacy.
Annual Monitoring
Data from the first time NAPLEX passing rate and the number of students admitted to the first professional year of study for each college or school was reviewed. Programs outside the respective monitoring boundaries were sent letters to request their explanation.
Self-Study and On-Site Evaluation Guidance
Self-study and on-site evaluation guidance was provided during the American Association of Colleges of Pharmacy (AACP) Council of Deans/Council of Faculties (COD/COF) Interim Meeting in Richmond, VA. The agenda provided opportunity for general discussion of procedures, self-study development, the independent analysis of the self-study by the evaluation team, and review of selected case studies. Individualized guidance regarding preparation for evaluations is routinely provided, through telephone conversations, discussions at national meetings, and visits to the Council office. Self-study guidance was also provided to the University of Illinois at Chicago College of Pharmacy, St. Louis College of Pharmacy, the University of Oklahoma College of Pharmacy, and the University of South Carolina College of Pharmacy. In addition, the ACPE professional staff conducted an educational session on the status of the implementation of Standards 2000 at the AACP Annual Meeting in San Diego, CA. Many college and school of pharmacy representatives who were soon to be evaluated by ACPE attended this session.
Evaluation Team Member Training
Review of the accreditation process, with a special focus on the role and responsibilities of evaluation team members, was conducted during the ACPE Evaluation Team Training Session, February 26, 2000, during the AACP COD/COF Interim Meeting in Richmond, VA. The agenda provided opportunity for discussion of the accreditation process generally, discussion of the on-site visit, including guidelines for team members and development of the evaluation team report, case studies with a focus on self-study analysis and interview skills. Evaluation and outcome measures were discussed. Specific guidance is also provided to evaluation team members during the orientation session of the on-site evaluation.
CONTINUING EDUCATION PROGRAM
Applications for Initial Accreditation as a Provider of Continuing Pharmaceutical Education
A total of 24 sets of application materials, submitted by organizations requesting ACPE-accreditation status as Providers of continuing pharmaceutical education were evaluated for presentation to the Council during 2000. These sets of application materials included both preliminary Requests for Evaluation and the more detailed Application Questionnaires. The following organizations were evaluated for consideration of initial accreditation: Academy of Medicine of New Jersey; Adheris, Inc.; ArcMesa Educators, Inc.; Bayer Institute for Health Care Communication; Bayshore Medical Center; BioMed General; The Center for Advanced Medical Education; Creative Educational Concepts, Inc.; Discovery International; e– edcredit.com; Gentiva Health Services; Health Science Center for Continuing Medical Education; Louisiana State University Health Sciences Center-Shreveport; Lovelace Health Systems; Orphan Medical, Inc; Parkland Health & Hospital System; ProCE, Inc.; RxFactStat; Saint Thomas Hospital Pharmacy Department; Slack Incorporated; Thomas R. Beam, Jr. Memorial Institute for Continuing Medical Education; University of South Florida College of Medicine; University of Texas Health Care at Tyler; and, Walgreens Health Initiatives.
Petitions for Continued Accreditation as a Provider of Continuing Pharmaceutical Education
A total of 63 Petitions for Continued Accreditation were reviewed. Each review entailed an evaluation of a variety of materials reflecting the Provider’s activity, including example continuing pharmaceutical education programs, a self-assessment report, surveys of program participants and, when available, program reviews by State Board of Pharmacy members. Petitions for Continued Accreditation submitted by the following Providers in 2000 were evaluated for presentation to the Council: Academy of Health Sciences, AMEDD Center and School; Alabama Society of Health-System Pharmacists; Alaska Pharmaceutical Association; Albany College of Pharmacy Union University; American Academy of Clinical Toxicology, Inc.; American College of Clinical Pharmacology; American College of Clinical Pharmacy; American Society for Clinical Pharmacology and Therapeutics; AmeriNet Central; Atlanta Academy of Institutional Pharmacists; Bismarck Continuing Medical Education Council; Brookdale Hospital Medical Center Department of Pharmacy Services; California Pharmacists Association Educational Foundation; CVS Clinical Services; The Detroit Medical Center Department of Pharmacy Services; Drake University College of Pharmacy and Health Sciences; Drug Store News; Florida A&M University College of Pharmacy and Pharmaceutical Sciences; The Food and Drug Law Institute, Inc.; G&A Medical Personnel, Inc.; Howard University College of Pharmacy, Nursing and Allied Health Sciences; Illinois Pharmacists Association; Indian Health Service Clinical Support Center; Institute for Continuing Healthcare Education; James A. Haley Veterans’ Hospital; Kansas Pharmacists Association; Lippincott Williams & Wilkins; Louisiana Society of Health-System Pharmacists; McKesson BioServices, Inc.; MED2000, Inc.; Medical Education Systems, Inc.; MediCom of Princeton, Inc.; North Dakota State University College of Pharmacy; Office of Health Policy and Clinical Outcomes, Thomas Jefferson University Hospital; The Ohio State University College of Pharmacy; Pennsylvania Pharmacists Association; Pfizer-U.S. Pharmaceuticals Group; Pharmaceutical Education & Research Institute, Inc. (PERI); Power-Pak C.E.; Professional Education Services Group; Purdue University School of Pharmacy and Pharmaceutical Sciences; Rhode Island Society of Health-System Pharmacists; Saint Vincent Hospital Department of Pharmacy; Saudi Pharmaceutical Society c/o King Saudi University College of Pharmacy; Sharp HealthCare; South Carolina Pharmacy Association; Sparrow Hospital; St. Vincent Hospitals and Health Services, Department of Pharmacy; Sunrise Medical; Texas Children’s Hospital Pharmacy; Tufts University School of Medicine, Office of Continuing Education; University at Buffalo School of Pharmacy; University of Arkansas for Medical Sciences College of Pharmacy; University of Colorado School of Pharmacy; University of Connecticut School of Pharmacy; University of Kansas School of Pharmacy; University of Montana School of Pharmacy and Allied Health Services; Utah Pharmaceutical Association; VA New York Harbor Healthcare System; Vanderbilt University Hospital Department of Pharmaceutical Services; Washington State Pharmacists Association; Western University of Health Sciences, College of Pharmacy; and, Xavier University of Louisiana College of Pharmacy.
Monitoring During the Accreditation Period Interim Reports
Based upon previous Council accreditation actions, 110 interim reports were received during the year. These reports were analyzed against the issues noted in the earlier accreditation actions, and were presented for the Council’s consideration.
Progress Reports
Based upon previous Council accreditation actions, 33 progress reports were received during the year. These reports were analyzed against the issues noted in the earlier accreditation actions, and were presented for the Council’s consideration.
Discontinued Providers
At the June 2000 and January 2001 meetings, five organizations were discontinued as ACPE-accredited providers of continuing pharmaceutical education.
On-going Monitoring
ACPE staff continued daily monitoring of accredited providers through review of Program Description Forms (PDFs) and Certificate Program Description Forms (CPDFs), responses to questions and requests for information from accredited providers, and follow-up to written complaints received regarding specific providers and/or continuing pharmaceutical education program offerings.
Provider Guidance
During 2000, ACPE professional staff provided extensive technical assistance, consultation, and other resources to accredited providers as well as others seeking assistance. The policy of inviting providers to meet with ACPE staff in Chicago or at other locations of mutual convenience continues to serve as an effective educational and communication purpose. On June 21, 2000, the professional staff visited Nebraska to provide guidance to the Nebraska Council on Continuing Education on CE accreditation issues. On January 27, 2000, in Chicago, Illinois, and on July 9, 2000, in San Diego, California, the ACPE staff met with the AACP Continuing Education (CE) Section Task Force on ACPE Relations.
Administrator workshops continue to be well received. These sessions include administrators from newly accredited providers as well as administrators from established provider organizations and are designed to provide a working knowledge of the Criteria for Quality and Interpretive Guidelines and their application to providers’ programs. Six workshops were offered in Chicago in 2000 with total attendance of 107 participants.
ACPE’s 9th Invitational Conference
The 9th Invitational Conference on Continuing Pharmaceutical Education will be held November 1-4, 2001, in the Phoenix, Arizona. For more information, contact ACPE.
Certificate Programs in Pharmacy
Notification of intent to offer Certificate Programs in Pharmacy has been received from 30 Providers and acknowledged.
ACPE ORGANIZATION AND ADMINISTRATION
Board of Directors and New Officers
The officers and members of the Board of Directors (as of January 14, 2001) are: Robert J. Osterhaus, RPh, President, and Community Pharmacy Practitioner and Owner, Osterhaus Pharmacy, Inc., Maquoketa, Iowa; Judith S. Christensen, PharmD, BCPS, RPh, Vice President, and Clinical Pharmacy Utilization Specialist, Munson Medical Center, Traverse City, Michigan; and, H.W. “Ted” Matthews, PhD, Secretary-Treasurer, and Professor of Pharmaceutical Sciences and Dean of Mercer University Southern School of Pharmacy, Atlanta, Georgia; Paul G. Boisseau, RPh, ScD, Executive Secretary, New Hampshire Board of Pharmacy, Concord, New Hampshire; Barbara F. Brandt, PhD, Assistant Vice President for Education and Professor of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy, Minneapolis, Minnesota; Dennis K. Helling, PharmD, FCCP, FASHP, Pharmacy Operations Director, Rocky Mountain Division, Kaiser Permanente, Aurora, Colorado; John R. Johannes, PhD, Vice President for Academic Affairs, Villanova University, Villanova, Pennsylvania; Mary Anne Koda-Kimble, PharmD, Professor of Clinical Pharmacy and Dean of the University of California, San Francisco School of Pharmacy, San Francisco, California; Wm. Whitaker Moose, RPh, ScD, Community Pharmacy Practitioner, Mt. Pleasant, North Carolina; and Terry A. Short, RPh, Director of Professional Services, CVS Corporation, Woonsocket, Rhode Island.
Professional Staff
Kimberly K. Werner resigned her position as Executive Associate Director on April 15, 2000, to seek new opportunities. Dawn G. Zarembski, PharmD, BCPS, joined the ACPE staff on July 17, 2000, as Executive Assistant Director. Dr. Zarembski is a graduate of the University of Illinois at Chicago College of Pharmacy and completed a residency and fellowship training at the University Medical Center, Tucson, Arizona, where she concentrated on cardiovascular drug therapy. During the last five years, Dawn served on the faculty of the Chicago College of Pharmacy (CCP), having a clinical practice base at Rush Presbyterian St. Luke’s Medical Center in Chicago. She had been recently promoted to Associate Professor of Pharmacy Practice at CCP with tenure. Dawn participates in both the professional degree program and continuing education provider accreditation activities.
In 2000, the administrative staff of ACPE consisted of Peter H. Masses, PharmD, BCPS, Executive Director; Jeffrey W. Wadelin, PhD, Executive Associate Director; Dimitra V. Travlos, PharmD, BCPS, Executive Assistant Director; Ulric K. Chung, PhD, Executive Assistant Director; Dawn G. Zarembski, PharmD, BCPS, Executive Assistant Director; Sharon L. Hudson, Assistant Director, Administrative Services. Dr. Wadelin is administratively heading the professional degree accreditation program and Drs. Masses and Travlos are administratively heading the CE provider accreditation program.
Public Interest Panel
Two new appointments were made to the Public Interest Panel: Sandra J. Branch, BS, JD, LLM, a corporate and real estate lawyer (replaced Frank Raymond, who resigned due to the press of business activities) and Stephen Dome, BA in Economics and MBA in International Finance, who is retired from a 30-year working career with First Chicago Corp./NBD/ Bank One. Both new members are from Glen Ellyn, Illinois. The third member, Joal Marie Hill, JD, MPH, Senior Research Scholar of the Park Ridge Center for the Study of Health, Faith and Ethics, Chicago, Illinois, will continue to serve as a member of the Public Interest Panel.
Evaluation Team Members
The success of the on-site evaluation depends upon the substantial efforts and dedication of many individuals (in addition to Council members and staff) who serve voluntarily as evaluation team members. Both academic and practice oriented individuals served during the year. These are: Mignon S. Adams, Director of Library Information Services and Associate Professor, J.W. England Library, University of the Sciences in Philadelphia; Diane E. Beck, Professor of Clinical Practice, Auburn University School of Pharmacy; Curtis D. Black, Assistant Dean and Merck Professor of Clinical Pharmacy, University of Toledo College of Pharmacy; Kim L. R. Brouwer, Professor of Pharmaceutics, University of North Carolina Chapel Hill School of Pharmacy; Bobby G. Bryant, Dean and Professor, Ohio Northern University College of Pharmacy; Barry L. Carter, Chair and Professor of Pharmacy Practice, University of Colorado Health Sciences Center School of Pharmacy; John L. Colaizzi, Dean and Professor of Pharmacy Practice, Rutgers University, the State University of New Jersey College of Pharmacy; Bruce L. Currie, Professor of Pharmaceutical Sciences, Midwestern University Chicago College of Pharmacy; Lisa Deziel-Evans, Associate Professor of Pharmacy Practice, Nova Southeastern University College of Pharmacy; JoLaine R. Draugalis, Assistant Dean and Professor, Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy; Jack E. Fincham, Dean and Professor of Pharmacy Practice, University of Kansas College of Pharmacy; George E. Francisco, Jr., Associate Dean and Associate Professor of Pharmacy, University of Georgia College of Pharmacy; Thomas S. Foster, Director, Center for Pharmaceutical Science and Technology, and Professor of Pharmacy and Anesthesia, University of Kentucky College of Pharmacy; Kimberly A. Gait, Associate Professor of Pharmacy Practice, Creighton University School of Pharmacy and Allied Health Professions; Michael C. Gerald, Dean and Professor, University of Connecticut School of Pharmacy; Dick R. Gourley, Dean and Professor, University of Tennessee College of Pharmacy; Marcellus Grace, Professor, Xavier University of Louisiana College of Pharmacy; Stephen G. Hoag, Dean and Professor of Pharmacy Practice, Drake University College of Pharmacy and Health Sciences; Curtis A. Johnson, Professor of Pharmacy Practice, University of Wisconsin-Madison School of Pharmacy; Danny L. Lattin, Dean and Professor, South Dakota State University College of Pharmacy; William C. Lubawy, Associate Dean and Professor of Pharmacology, University of Kentucky College of Pharmacy; Michael W. McKenzie, Associate Dean for Professional Affairs and Professor, University of Florida College of Pharmacy; Ronald W. Maddox, Dean and Professor, Campbell University School of Pharmacy; Michael S. Maddux, Professor, Assistant Dean, and Department Head/Chair, Pharmacy Practice, St. Louis College of Pharmacy; Lloyd E. Matheson, Associate Dean for Professional Affairs and Associate Professor of Pharmaceutics, University of Iowa College of Pharmacy; John E. Murphy, Professor and Head, Department of Pharmacy Practice and Science, the University of Arizona College of Pharmacy; Ilia Oquendo, Dean, University of Puerto Rico School of Pharmacy; Charles D. Peterson, Dean and Professor of Pharmacy Practice, North Dakota State University College of Pharmacy; Charles 0. Rutledge, Dean and Professor of Pharmacology, Purdue University School of Pharmacy and Pharmacal Sciences; Robert D. Sindelar, Dean and Professor of Medicinal Chemistry, University of Mississippi School of Pharmacy; George R. Spratto, Dean and Professor of Pharmacology, West Virginia University Health Science Center North School of Pharmacy; Theodore G. Tong, Professor of Pharmacy Practice, Pharmacology and Toxicology and Associate Dean for Academic Affairs, University of Arizona College of Pharmacy; John H. Vandel, community pharmacy practitioner, Vandel Drugs; R. Pete Vanderveen, Dean and Professor of Pharmaceutics, Duquesne University Mylan School of Pharmacy; and Melvin H. Weinswig, Dean and Professor, University of Wisconsin-Madison School of Pharmacy.
Board of Pharmacy Representation
The following representatives of the Board of Pharmacy of the states in which the College or School of Pharmacy is located worked with the evaluation teams: Pamela Allen, Rutgers, the State University of New Jersey; Ann Breakenridge, Howard University; Kim A. Caldwell, Texas Tech University Health Sciences Center; James Carder, University of Wyoming; Gay Dodson, Texas Southern University Lawrence J. Kost, University of Cincinnati; Linda Labenz, University of Nebraska; Terry T. Lewis, University of South Carolina; Olena Maleckkyj-Popowycz, Midwestern University; Steve Meloy, University of Montana; Pauline R. Montgomery, Wilkes University; Mark A. Oley, Shenandoah University; Bryan H. Potter, University of Oklahoma; Morris Rabb, University of Louisiana at Monroe; Harold Sparr, Massachusetts College of Pharmacy and Health Sciences-Worcester; Harold J. Stamps, University of Mississippi; Clay Wilson, Auburn University; and, Donald K. Yee, University of Maryland.
Observers
Dr. Richard P. Penna, Executive Vice President of the American Association of Colleges of Pharmacy (AACP), served as an observer on the evaluation team at Wilkes University Nesbitt School of Pharmacy; Dr. Susan M. Meyer, Senior Vice President of AACP, served as an observer on the evaluation team at Midwestern University Chicago College of Pharmacy; and Dr. Kenneth W. Miller, Vice President, Graduate Education, Research and Scholarship, served as an observer on the evaluation team at the University of Maryland School of Pharmacy. This activity was conducted as a part of an information exchange and communication procedure.
Committee on Continuing Education
On September 7-8, 2000, in Chicago, Illinois, the ACPE staff hosted a meeting of a committee of CE providers to receive additional feedback for the strategic planning process. Representing the ACPE Board of Directors was Judith S. Christensen, PharmD, BCPS, RPh, Clinical Pharmacy Utilization Specialist, Munson Medical Center. The CE providers who were selected from those that volunteered to serve on the committee were: James Appleby, RPh, MPH, Vice President, Professional Education & Industry Relations, American Pharmaceutical Association; Alan Escovitz, PhD, Director, Continuing Education, The Ohio State University College of Pharmacy; William Feinberg, MBA, RPh, President, W-F Professional Associates, Inc; Anita Groves, MS, RPh, Administrator, Owen Healthcare, Inc.; Barbara Hammonds, MS, Director Educational Services Division, American Society of Health-System Pharmacists; Peggy Kuehl, PharmD, BCPS, FCCP, Director, Education and Member Services, American College of Clinical Pharmacy; James Magrann, Executive Director of Continuing Education, Lippincott Williams & Wilkins; Jonathan Marquess, PharmD, Director, Continuing Education & Professional Affairs, Mercer University Southern School of Pharmacy; Jennifer Moulton, RPh, Senior Vice President, Professional & Educational Affairs, Iowa Pharmacy Association; Linda Norton, PharmD, Director of Postgraduate Professional Education, University of the Pacific School of Pharmacy and Health Sciences; Thomas O’Connor, PharmD, MBA, Director, Division of Continuing Pharmaceutical Education, Temple University School of Pharmacy; and, James Prazak, RPh, Associate Director, Continuing Education & Accreditation, BristolMyers Squibb Company. Feedback from the committee contributed to the strategic planning process.
Field Reviewers
During 2000, the following individuals contributed their time and effort in support of the Provider Accreditation Program by serving as a field reviewer in the Petition for Continued Accreditation process: Carmen Aceves-Blumenthal, Nova Southeastern University College of Pharmacy; George Alexis, VA Boston Healthcare System; Howard C. Anderson, Executive Director, North Dakota State Board of Pharmacy; Robert Beardsley, Professor and Associate Dean, University of Maryland School of Pharmacy; Robert W. Bennett, Director of Pharmacy Continuing Education, Purdue University School of Pharmacy and Pharmaceutical Sciences; Malcolm Broussard, Executive Director, Louisiana Board of Pharmacy; Bruce Carlstedt, Professor of Pharmacy Practice, Purdue University School of Pharmacy; Robert Cavendish, Vice President, Ohio State Board of Pharmacy; Curtis D. Black, Assistant Dean and Merck Professor of Clinical Pharmacy, The University of Toledo College of Pharmacy; Barry Bleidt, Director of Professional Programs, Hampton University School of Pharmacy; Jack L. Coffey, Clinical Associate Professor and Interim Assistant Dean, University of Oklahoma College of Pharmacy; Joseph 0. Dean, Dean, Samford University McWhorter School of Pharmacy; Lisa Deziel-Evans, Assistant Dean for Academic Innovation and Technology, Nova Southeastern University College of Pharmacy; Wendy Force, Continuing Education Administrator, Idaho State University College of Pharmacy; Darlene Fujimoto, California State Board of Pharmacy; Virginia Galizia, Professor, Idaho State University College of Pharmacy; Kimberly Galt, Associate Professor of Pharmacy Practice, Creighton University School of Pharmacy and Allied Health Professions; H.C. Trey Gardner III, Continuing Education Administrator, University of Arkansas for Medical Sciences College of Pharmacy; Kristin Janke, Director of Outreach Education, University of Minnesota College of Pharmacy; Elizabeth Keyes, Director of Education, American Pharmaceutical Association; Susan Kleppin, Director of Educational Affairs, Pharmacy Society of Wisconsin; Linda Labenz, Secretary, Nebraska Board of Examiners in Pharmacy; Jonathan Marquess, Director, Continuing Education and Professional Affairs, Mercer University Southern School of Pharmacy; Dennis McAllister, Director of Experiential Education, Midwestern University, College of Pharmacy-Glendale; Thomas Mensing, Compliance Specialist, Montana Board of Pharmacy; David G. Miller, Director of Pharmacy Affairs, Merck & Co., Inc., Human Health Division; Marsha Millonig, Vice President of Information Services, National Wholesale Druggists Association; Gladys Miro de Rivera, Associate Dean, University of Puerto Rico School of Pharmacy; Karen L. Moore, Coordinator, Continuing Education, Ferris State University College of Pharmacy; Milagros Morales, Puerto Rico Board of Pharmacy; Audrey Neely, Manager of Professional Affairs, Illinois Department of Regulations; Anna Leonhardt, Administrator, Maryland Pharmacy Continuing Education Coordinating Council; Albert Lockamy, North Carolina Board of Pharmacy; Elizabeth Loftis-Brusig, Continuing Education Coordinator, Virginia Society of Health-System Pharmacists; Thomas O’Connor, Director, Division of Continuing Pharmaceutical Education, Temple University School of Pharmacy; William M. Ozburn, Senior Public Service Associate, University of Georgia College of Pharmacy; Lois Parker, Senior Attending Pharmacist, Massachusetts General Hospital Department of Pharmacy VBK BA 020; Susan Peverly, Assistant Dean for Academic Affairs, University of Illinois at Chicago College of Pharmacy; Therese Poirier, Professor of Clinical Pharmacy, Duquesne University School of Pharmacy; James Prazak, Associate Director, Continuing Education and Accreditation, Bristol-Myers Squibb Company; Cindy Porter, Director, Educational Affairs, American Society of Consultant Pharmacists; Brian Russell, Executive Director, CoMed Communications; Domenic Sammarco, Connecticut Pharmacist Association; Ginger Scott, Director of Continuing Education, West Virginia University School of Pharmacy; Michael L. Simeone, Director of Continuing Education, University of Rhode Island College of Pharmacy; Sharon Stevens Small, Director of Continuing Education, Virginia Council on Pharmaceutical Education; Robert E. Smith, Department Head and Chair, Clinical Pharmacy Practice, Auburn University School of Pharmacy; Harold B. Sparr, President, Massachusetts Board of Registration in Pharmacy; William Tiffany, Virginia Board of Pharmacy; Donna Wall, Clarian Health Partners; Jack Glenn Watts, North Carolina Board of Pharmacy; Timothy Welty, Associate Professor of Pharmacy Practice, Samford University McWhorter School of Pharmacy; Barbara Woods, Director of Continuing Education, University of Kansas School of Pharmacy; and, Anita Young, Director of Continuing Education, Massachusetts College of Pharmacy and Health Sciences.
Strategic Planning Process Survey
In June 2000, the Council reviewed a summary of the results from the ACPE 2000 Strategic Planning survey conducted and reported by Consulting Dynamics Incorporated. The web-based survey received 838 responses from all segments of the profession (colleges and schools of pharmacy [Deans, administrators, faculty, students], administrators of continuing education providers, evaluation team members, Public Interest Panel members, field reviewers, practitioners, national professional pharmacy associations, etc.). In general, ACPE accreditation activities were well received and valued by the profession. Constructive criticisms as well as written comments were presented along with suggested actions.
Retreat
The ACPE Board and administrative staff participated in a Strategic Planning retreat in Bigfork, Montana, from September 29 to October 1, 2000. The participants heard presentations by the following invited speakers: Cynthia A. Davenport, Executive Director, Association of Specialized & Professional Accreditors (ASPA); George E. Downs, PharmD, Dean, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia; Alan L. Hanson, PhD, Chair, Extension Services in Pharmacy, Associate Dean for Outreach, School of Pharmacy, University of Wisconsin-Madison; Karen W. Kershenstein, PhD, Director, Accreditation and State Liaison, U.S. Department of Education; Wolfgang Sadee, PhD, Professor and Vice Chair, Department of Biopharmaceutics and Science, University of California, San Francisco; Ralph Wolff, JD, Executive Director, The Senior College Commission, Western Association of Schools & Colleges (WASC); and, David A. Zitz, RPh, MS, Pharmacy Consultant. The results of the ACPE 2000 Strategic Planning survey and a strengths/weaknesses/opportunities/threats (SWOT) analysis by the participants were discussed, as well as possible “critical issues” for ACPE to consider in the next 3-5 years. The group prepared a draft Strategic Plan, which included a new statement of core ideology and a revised mission statement, as well as the listing of the four highest prioritized critical issues along with proposed goals under each critical issue.
Strategic Plan
The draft ACPE 2000 Strategic Plan was distributed in November 2000, to Deans of colleges and schools of pharmacy, administrators of continuing education providers, evaluation team members, field reviewers, Public Interest Panel members, and all national professional pharmacy associations, with a request for additional comments and feedback. The Council received and assessed comments from external review by ACPE constituencies regarding the draft Strategic Plan and further developed the Plan. The Plan will be a dynamic document that will continue to be reviewed, acted on and modified at future ACPE Board meetings. ACPE wishes to thank everyone who participated in the strategic planning process for their valued input.
Publications and Distribution
ACPE published the Annual Directory of Professional Programs of Colleges and Schools of Pharmacy (5000 copies distributed) and the Directory of Accredited Providers of Continuing Pharmaceutical Education (3500 copies distributed). The pharmacy press was invited to reproduce this Directory in their publications. These publications provide both program/provider accreditation information and public information regarding the ACPE accreditation processes. The ACPE Accreditation Manual 9th Edition (I’t Printing, September 2000) was distributed to the Colleges and Schools of Pharmacy and the national pharmaceutical associations. ACPE Newsletters were published twice during the year, in January and July. The July 2000 Newsletter included a listing of the programs of Colleges and Schools of Pharmacy to be considered for accreditation/preaccreditation during the 2000-2001 academic year. Opportunity was given for the submission of written third party comments concerning qualifications for accreditation or preaccreditation. Written third party comments were to be received by September 1, 2000, for fall 2000 reviews, and by November 1, 2000, for spring 2001 reviews. No comments were received.
Staff Communication and Outreach Activities
In 2000, the ACPE staff met with, attended and/or presented at the national meetings of the following organizations to maintain effective relationships with all pharmacy organizations at the national and state level, including: AACP, AAMC, ACCP, AFPE, AMCP, APhA, ASHP, ASPA, CCP, CHEA, JCPP, NABP, NACDS, PCMA, PSHP, the International Conference on Life-Long Learning in Pharmacy, the International Conference on Pharmacy Competence, and the National Task Force on CME Provider/Industry Collaboration; as well as hosting a Field Reviewer Training Workshop with a number of state boards of pharmacy executives, and an Open Forum on ACPE CE Provider Accreditation Issues.
Peter H. Masses and Jeffrey W. Wadelin
The American Council on Pharmaceutical Education, 311 West Superior Street, Chicago IL 60610-3537
Copyright American Association of Colleges of Pharmacy Winter 2001
Provided by ProQuest Information and Learning Company. All rights Reserved
